应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PODD 银休特
未开盘 05-10 16:00:00 EDT
165.90
-11.63
-6.55%
盘后
166.50
+0.60
+0.36%
19:49 EDT
最高
193.30
最低
162.72
成交量
317.64万
今开
181.87
昨收
177.53
日振幅
17.23%
总市值
116.17亿
流通市值
115.50亿
总股本
7,002万
成交额
5.46亿
换手率
4.56%
流通股本
6,962万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-竞争对手标榜需求强劲,天德糖尿病公司业绩上升
Reuters · 05-10 23:38
BUZZ-竞争对手标榜需求强劲,天德糖尿病公司业绩上升
BUZZ-Insulet 因上调 2024 年收入增长预期而攀升
Reuters · 05-10 21:52
BUZZ-Insulet 因上调 2024 年收入增长预期而攀升
Insulet Corp 预计每股收益39美分 - 财报前瞻
Reuters · 05-08
Insulet Corp 预计每股收益39美分 - 财报前瞻
Wolfe Research:上调Insulet(PODD.US)评级,由Peer Perform调整至优于大市评级, 目标价200.00美元。
智通财经 · 05-07
Wolfe Research:上调Insulet(PODD.US)评级,由Peer Perform调整至优于大市评级, 目标价200.00美元。
银休特盘中异动 股价大涨5.02%报178.57美元
自选股智能写手 · 04-09
银休特盘中异动 股价大涨5.02%报178.57美元
银休特盘中异动 早盘股价大跌5.03%报166.71美元
自选股智能写手 · 03-14
银休特盘中异动 早盘股价大跌5.03%报166.71美元
银休特盘中异动 股价大涨5.11%报174.17美元
自选股智能写手 · 03-08
银休特盘中异动 股价大涨5.11%报174.17美元
银休特盘中异动 快速跳水5.23%报174.58美元
自选股智能写手 · 02-26
银休特盘中异动 快速跳水5.23%报174.58美元
银休特2023财年实现净利润2.06亿美元,同比增加4378.26%
自选股智能写手 · 02-26
银休特2023财年实现净利润2.06亿美元,同比增加4378.26%
银休特盘中异动 早盘快速跳水5.68%
自选股智能写手 · 02-23
银休特盘中异动 早盘快速跳水5.68%
美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra
Reuters · 02-23
美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra
BUZZ-Insulet 因年度收入增长预期低于预期而下跌
Reuters · 02-23
BUZZ-Insulet 因年度收入增长预期低于预期而下跌
更新版 1-Insulet 预测全年收入增长乏力,股价下跌
Reuters · 02-23
更新版 1-Insulet 预测全年收入增长乏力,股价下跌
胰岛素泵需求强劲,Insulet 季度利润超预期
Reuters · 02-23
胰岛素泵需求强劲,Insulet 季度利润超预期
银休特涨3.49% 股价突破200美元大关
自选股智能写手 · 02-07
银休特涨3.49% 股价突破200美元大关
美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡
Reuters · 02-01
美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡
银休特涨2.36% 股价突破200美元大关
自选股智能写手 · 01-30
银休特涨2.36% 股价突破200美元大关
加载更多
公司概况
公司名称:
银休特
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。
发行价格:
--
{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"银休特","latestPrice":165.9,"timestamp":1715371200000,"preClose":177.53,"halted":0,"volume":3176395,"hourTrading":{"tag":"盘后","latestPrice":166.5,"preClose":165.9,"latestTime":"19:49 EDT","volume":76877,"amount":12754954.17,"timestamp":1715384983791},"delay":0,"floatShares":69622503,"shares":70022493,"eps":2.942973,"marketStatus":"未开盘","marketStatusCode":0,"change":-11.63,"latestTime":"05-10 16:00:00 EDT","open":181.87,"high":193.3,"low":162.715,"amount":545756277.41875,"amplitude":0.172281,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.942973,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715587200000},"adr":0,"listingDate":1179201600000,"adjPreClose":177.53,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":182,"preClose":177.53,"latestTime":"09:29 EDT","volume":19970,"amount":3530974.5815000003,"timestamp":1715347799962},"postHourTrading":{"tag":"盘后","latestPrice":166.5,"preClose":165.9,"latestTime":"19:49 EDT","volume":76877,"amount":12754954.17,"timestamp":1715384983791},"volumeRatio":3.094313206101016},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"2434865849","title":"BUZZ-竞争对手标榜需求强劲,天德糖尿病公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2434865849","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434865849?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:38","pubTimestamp":1715355508,"startTime":"0","endTime":"0","summary":" 5月10日 - ** 在竞争对手Insulet Corp 上调 ,Tandem Diabetes Care 股价上涨2.81%,报45.29美元。** Insulet上调了年收入增长预期,这主要得益于其可穿戴无管胰岛素泵的强劲销售 。** LSEG 数据显示,PODD 目前认为其财政年度收入增长率为 14%-18%,而此前预期为 12%-17%,高于分析师平均预期的 15.62%。** 5 月早些时候,TNDM 还将财年销售额预期从 8.5 亿美元上调至 8.68 亿美元。** TNDM 今年以来的涨幅约为 52.65","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434418854","title":"BUZZ-Insulet 因上调 2024 年收入增长预期而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2434418854","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434418854?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:52","pubTimestamp":1715349164,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月10日 - ** 医疗设备制造商Insulet 股价上涨5.3%至187.06美元 ** 该公司认为 (link) 全年收入增长介于 14% 至 18% 之间,高于之前预期的 12% 至 17% - LSEG 数据** 该公司第一季度总收入增长超过 23%,达到 4.417 亿美元,而分析师平均预期为 4.2405 亿美元。 ** 截至收盘,股价累计下跌 18.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433321757","title":"Insulet Corp 预计每股收益39美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433321757","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433321757?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:13","pubTimestamp":1715127222,"startTime":"0","endTime":"0","summary":" * Insulet公司 预计将在5月9日公布截至2024年3月31日的季度收入报告。* 根据LSEG的数据,18位分析师的平均预期显示,这家总部位于马萨诸塞州阿克顿的公司的营收将从去年同期的3.581亿美元增长18.4%,达到4.245亿美元。* LSEG 分析师对 Insulet 公司的平均预期为每股收益 39 美分。* 华尔街对 Insulet Corp 的 12 个月目标价中位数为 238.00 美元,高于其最新收盘价 184.28 美元。5月8日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433227674","title":"Wolfe Research:上调Insulet(PODD.US)评级,由Peer Perform调整至优于大市评级, 目标价200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433227674","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433227674?lang=zh_cn&edition=full","pubTime":"2024-05-07 17:45","pubTimestamp":1715075126,"startTime":"0","endTime":"0","summary":"Wolfe Research:上调Insulet(PODD.US)评级,由Peer Perform调整至优于大市评级, 目标价200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050717452987dbf96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050717452987dbf96b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426115836","title":"银休特盘中异动 股价大涨5.02%报178.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426115836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426115836?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:25","pubTimestamp":1712672739,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时25分,银休特股票出现波动,股价快速拉升5.02%。截至发稿,该股报178.57美元/股,成交量13.0343万股,换手率0.19%,振幅4.68%。最近的财报数据显示,该股实现营业收入16.97亿美元,净利润2.06亿美元,每股收益2.96美元,毛利11.68亿美元,市盈率60.62倍。机构评级方面,在所有23家参与评级的机构中,83%的券商给予买入建议,17%的券商给予持有建议,无券商给予卖出建议。银休特股票所在的医疗器械行业中,整体涨幅为0.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409222539791f6caf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409222539791f6caf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419698541","title":"银休特盘中异动 早盘股价大跌5.03%报166.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419698541","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419698541?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:53","pubTimestamp":1710427996,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日22时53分,银休特股票出现异动,股价快速下跌5.03%。截至发稿,该股报166.71美元/股,成交量25.5864万股,换手率0.37%,振幅5.38%。银休特股票所在的医疗器械行业中,整体跌幅为0.92%。结果是 Omnipod 系统,它由一个小型一次性胰岛素输注设备组成,可以通过智能手机操作以控制剂量。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314225316791a7fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314225316791a7fc8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417864799","title":"银休特盘中异动 股价大涨5.11%报174.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417864799","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417864799?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:00","pubTimestamp":1709827218,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日00时00分,银休特股票出现波动,股价急速上涨5.11%。截至发稿,该股报174.17美元/股,成交量24.4944万股,换手率0.35%,振幅4.00%。银休特股票所在的医疗器械行业中,整体涨幅为1.08%。结果是 Omnipod 系统,它由一个小型一次性胰岛素输注设备组成,可以通过智能手机操作以控制剂量。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800001879184a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800001879184a4f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414083523","title":"银休特盘中异动 快速跳水5.23%报174.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414083523","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414083523?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:07","pubTimestamp":1708960044,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时07分,银休特股票出现波动,股价急速下挫5.23%。截至发稿,该股报174.58美元/股,成交量19.2802万股,换手率0.28%,振幅5.43%。机构评级方面,在所有23家参与评级的机构中,83%的券商给予买入建议,17%的券商给予持有建议,无券商给予卖出建议。银休特股票所在的医疗器械行业中,整体跌幅为0.35%。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262307247914b470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262307247914b470&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414091353","title":"银休特2023财年实现净利润2.06亿美元,同比增加4378.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414091353","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414091353?lang=zh_cn&edition=full","pubTime":"2024-02-26 00:21","pubTimestamp":1708878108,"startTime":"0","endTime":"0","summary":"12月31日,银休特公布财报,公告显示公司2023财年净利润为2.06亿美元,同比增加4378.26%;其中营业收入为16.97亿美元,同比增加30.04%,每股基本收益为2.96美元。从资产负债表来看,银休特总负债18.56亿美元,其中短期债务52.90百万美元,资产负债比为1.40,流动比率为3.48。机构评级:截至2023年12月31日,当前有20家机构对银休特目标价做出预测,其中目标均价为236.52美元,其中最低目标价为208.00美元,最高目标价为270.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600215587bdd958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022600215587bdd958&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413629717","title":"银休特盘中异动 早盘快速跳水5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413629717","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413629717?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:32","pubTimestamp":1708698748,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时32分,银休特股票出现异动,股价大幅下挫5.68%。截至发稿,该股报185.94美元/股,成交量4.7644万股,换手率0.07%,振幅3.01%。银休特股票所在的医疗器械行业中,整体跌幅为0.38%。结果是 Omnipod 系统,它由一个小型一次性胰岛素输注设备组成,可以通过智能手机操作以控制剂量。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322322881ae794e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322322881ae794e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":" 路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻 * Biomarin Pharmaceutical Inc :Piper Sandler将目标价从115美元下调至107美元 * Intuit Inc :Susquehanna将目标价从700美元上调至775美元 * Penumbra Inc :摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273169","title":"BUZZ-Insulet 因年度收入增长预期低于预期而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273169","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273169?lang=zh_cn&edition=full","pubTime":"2024-02-23 07:03","pubTimestamp":1708642990,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 2月22日 - ** 胰岛素输送系统制造商Insulet 股价在延时交易中下跌5.7%,报186美元。** PODD预计2024年全年收入增长12%至17%,中间值低于LSEG预计的16.6%。** 由于对可穿戴无管胰岛素泵的需求强劲,公司第四季度利润和收入仍超出预期** 第四季度营收增长 37.9%,达到 5.098 亿美元,高于伦敦证交所集团预计的 4.611 亿美元** 第四季度每股收益为1.40美元,超出预期的66美分。** 2023 年,PODD 下降了 26.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413278278","title":"更新版 1-Insulet 预测全年收入增长乏力,股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2413278278","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413278278?lang=zh_cn&edition=full","pubTime":"2024-02-23 06:58","pubTimestamp":1708642682,"startTime":"0","endTime":"0","summary":" 路透社2月22日 - Insulet Corp 周四预测全年收入增长低于预期,导致这家医疗设备制造商的股价在盘后交易中下跌超过6%。Insulet 生产和销售 \"Omnipod \"品牌的胰岛素给药设备,该设备使胰岛素依赖型糖尿病患者无需每天使用注射器或胰岛素笔进行多次注射。预计到 2024 年,Omnipod 的收入将增长 13% 至 18%。报告季度 Omnipod 的销售额为 5.01 亿美元,而分析师预计为 4.574 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413707229","title":"胰岛素泵需求强劲,Insulet 季度利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2413707229","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413707229?lang=zh_cn&edition=full","pubTime":"2024-02-23 05:07","pubTimestamp":1708636049,"startTime":"0","endTime":"0","summary":" 路透社2月22日 - Insulet Corp 周四公布的第四季度利润好于预期,主要得益于其可穿戴无管胰岛素泵的强劲销售。Insulet 生产和销售 \"Omnipod \"品牌的胰岛素给药设备,这种设备使胰岛素依赖型糖尿病患者无需每天使用注射器或胰岛素笔进行多次注射。不过,该设备制造商预计这些药物不会影响公司胰岛素泵的长期市场。Insulet 预计 2024 年全年的收入增长率在 12% 到 17% 之间,而 Omnipod 的收入增长率预计在 13% 到 18% 之间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409236438","title":"银休特涨3.49% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2409236438","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409236438?lang=zh_cn&edition=full","pubTime":"2024-02-07 04:50","pubTimestamp":1707252610,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日04时50分,银休特股票出现异动,股价快速拉升3.49%。截至发稿,该股报200.30美元/股,成交量33.3883万股,换手率0.48%,振幅2.97%。银休特股票所在的医疗器械行业中,整体涨幅为1.08%。银休特公司简介:Insulet 成立于 2000 年,其目标是使糖尿病的持续皮下胰岛素输注治疗更易于使用。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020704501087e6e422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020704501087e6e422&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408550592","title":"美国研究综述-美国电话电报公司、伦诺克斯国际公司、万事达卡","url":"https://stock-news.laohu8.com/highlight/detail?id=2408550592","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408550592?lang=zh_cn&edition=full","pubTime":"2024-02-01 17:08","pubTimestamp":1706778485,"startTime":"0","endTime":"0","summary":" 路透2月1日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价,其中包括美国电话电报公司、伦诺克斯国际公司和万事达卡公司。* 8X8 Inc :巴克莱将目标价从2.50美元上调至3美元 * AMD Inc :Northland Capital上调其评级至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407145778","title":"银休特涨2.36% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2407145778","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2407145778?lang=zh_cn&edition=full","pubTime":"2024-01-30 04:23","pubTimestamp":1706559797,"startTime":"0","endTime":"0","summary":"北京时间2024年01月30日04时23分,银休特股票出现波动,股价快速上涨2.36%。截至发稿,该股报200.07美元/股,成交量35.9859万股,换手率0.52%,振幅3.02%。银休特股票所在的医疗器械行业中,整体涨幅为0.98%。银休特公司简介:Insulet 成立于 2000 年,其目标是使糖尿病的持续皮下胰岛素输注治疗更易于使用。自 Omnipod 于 2005 年获得美国食品和药物管理局批准以来,全球约有 360,000 名胰岛素依赖型糖尿病患者正在使用它。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013004231787e69727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024013004231787e69727&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0489},{"period":"1month","weight":-0.0649},{"period":"3month","weight":-0.1384},{"period":"6month","weight":0.0696},{"period":"1year","weight":-0.4836},{"period":"ytd","weight":-0.2354}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":-0.004443},{"month":2,"riseRate":0.470588,"avgChangeRate":-0.007181},{"month":3,"riseRate":0.705882,"avgChangeRate":0.01102},{"month":4,"riseRate":0.470588,"avgChangeRate":0.022014},{"month":5,"riseRate":0.352941,"avgChangeRate":0.007551},{"month":6,"riseRate":0.823529,"avgChangeRate":0.048035},{"month":7,"riseRate":0.411765,"avgChangeRate":-0.009305},{"month":8,"riseRate":0.764706,"avgChangeRate":0.0696},{"month":9,"riseRate":0.529412,"avgChangeRate":0.008493},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.011821},{"month":11,"riseRate":0.647059,"avgChangeRate":0.081302},{"month":12,"riseRate":0.470588,"avgChangeRate":0.043302}],"exchange":"NASDAQ","name":"银休特","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银休特,PODD,银休特股票,银休特股票老虎,银休特股票老虎国际,银休特行情,银休特股票行情,银休特股价,银休特股市,银休特股票价格,银休特股票交易,银休特股票购买,银休特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}